Kamada Announces That It Had Successfully Met the Primary Endpoint in Its US Phase III Clinical Trial with Intravenous AAT

Kamada will being Phase II clincial tirals with inhaled version of its Alpha-1 Antitrypsin (AAT) product to treat Bronchiectasis.

The Alpha-1 Association is pleased to announce the launch of our new Alpha-1 Multi-Media Library.

FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) has entered into a definitive agreement with ProGenetics, LLC, a private company based in Blacksburg, Virginia, to obtain an exclusive license to develop and commercialize ProGenetics’ recombinant human factor IX, recombinant human factor VIII, and recombinant human fibrinogen for North America, Europe and Japan. ProGenetics is developing production of the human coagulation factors IX and VIII in the milk of transgenic pigs and has patents that cover the transgenic production of human fibrinogen. ProGenetics will receive a non-exclusive license to GTC’s patent in the United States for the transgenic expression of therapeutic proteins in milk to enable the commercial development of these products outside of North America, Europe and Japan. ProGenetics received $500,000 from GTC upon signing of the agreement and will receive approximately $500,000 from GTC in the second quarter of 2008. GTC will also receive a small equity interest in ProGenetics.

Researchers from Brigham and Women’s Hospital (BWH) and National Jewish Medical and Research Center in Denver have been awarded a $37 million grant from the National Heart Lung and Blood Institute (NHLBI) to lead the most comprehensive study of chronic obstructive pulmonary disease (COPD) ever undertaken.

Alpha-1 Association is partnering with CaringBridge to offer a new approach for Alpha families and friends to stay connected and share their experience.

National Jewish, Brigham and Women's Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD

The Alpha-1 Association is pleased to announce the launch of its new Alpha-1 Genetic Counseling Call Center.

The Alpha-1 Association has joined in collaboration with the American Association for Respiratory Care (AARC), the national organization of Respiratory Therapists, to move each organization’s legislative agenda forward.

March 2, 2007 - Membership Drive Underway